960289-61-6Relevant academic research and scientific papers
Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection
-
Page/Page column 116; 144; 145, (2018/10/25)
The present invention relates to novel compounds of formula (I), wherein R1, R2, R3, R4, R5 and R6 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
FUSED QUADRACYCLIC COMPOUNDS, COMPOSITIONS AND USES THEREOF
-
Paragraph 0383; 0420, (2017/08/01)
Provided herein are substituted fused quadracyclic compounds useful as inhibitors of MK2. The invention further provides pharmaceutical compositions of the compounds of the invention. The invention also provides medical uses of substituted fused quadracyclic compounds.
NOVEL MCH RECEPTOR ANTAGONISTS
-
Page/Page column 43, (2008/06/13)
The present invention relates to a melanin concentrating hormone antagonist compound of formula (I): wherein R1, Ra, Rb, R2, L1, R3, R4 and R5 are as defined, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diasteromers thereof useful in the treatment, obesity and related diseases.
